Search results for " DEMENTIA"

showing 10 items of 165 documents

Assessing natural metalinguistic skills in people with Alzheimer’s disease and frontotemporal dementia

2019

Abstract Objective The aim of this paper is to assess whether the use of natural metalinguistic skills can be used to differentiate linguistic-communicative profiles of people with dementia (Alzheimer’s disease and frontotemporal dementia in the behavioural and primary progressive aphasia variants) in the earliest stages of the disease. Method A sample of 180 people was selected. Sixty had Alzheimer’s disease, 20 had frontotemporal dementia of the behavioural variant, and 40 had frontotemporal dementia of the primary progressive aphasia variant (20 had non-fluent primary progressive aphasia and 20 had semantic dementia). The control group was composed of 60 healthy people with ages, gender,…

Linguistics and LanguageCognitive NeuroscienceSemantic dementiaLinguisticsExperimental and Cognitive PsychologyDiseaseNeuropsychological TestsLPN and LVNmedicine.diseaseAdditional researchTest (assessment)Primary progressive aphasiaSpeech and HearingAphasia Primary ProgressiveAlzheimer DiseaseFrontotemporal Dementiamental disordersmedicineHumansDementiaInternal validityPsychologyFrontotemporal dementiaClinical psychologyJournal of Communication Disorders
researchProduct

A systematic review of neuropsychiatric symptoms in mild cognitive impairment.

2009

Mild cognitive impairment (MCI) is a clinical concept proposed as an intermediate state between normal aging and dementia. This condition has multiple heterogeneous sources, including clinical presentation, etiology, and prognosis. Recently, the prevalence and associated features of neuropsychiatric symptoms (NPS) in MCI have been described. We systematically searched the PubMed database (last accessed on August 31, 2008) for articles on NPS in MCI. Included articles used strict selection criteria, and outcome variables were extracted in duplicate; of the 27 articles included, 14 (52%) used prospective cohorts. The global prevalence of NPS in MCI ranged from 35% to 85%. The most common beha…

medicine.medical_specialtyPopulationDiseaseNeuropsychological TestsIrritabilitybehavioral disciplines and activitiesAlzheimer DiseaseRisk FactorsInternal medicinemental disordersmedicineDementiaAlzheimer’s disease behavior dementia depression incidence mild cognitive impairment neuropsychiatric symptoms predictors prevalence risk factorsHumansProspective cohort studyeducationDepression (differential diagnoses)education.field_of_studyClinical Trials as TopicGeneral NeuroscienceMental DisordersGeneral Medicinemedicine.diseasePsychiatry and Mental healthClinical PsychologyEtiologyAnxietySettore MED/26 - NeurologiaGeriatrics and Gerontologymedicine.symptomPsychologyCognition DisordersClinical psychologyJournal of Alzheimer's disease : JAD
researchProduct

Risk of Hospitalized Falls and Hip Fractures in 22,103 Older Adults Receiving Mental Health Care vs 161,603 Controls: A Large Cohort Study.

2020

Abstract: Objectives: To investigate the risk of hospitalized fall or hip fracture among older adults using mental health services. Design: Retrospective cohort study. Setting and Participants: Residents of a South London catchment aged >60 years receiving specialist mental health care between 2008 and 2016. Measures: Falls and/or a hip fracture leading to hospitalization were ascertained from linked national records. Incidence rates and incidence rate ratios (IRRs) were age- and gender-standardized to the catchment population. Multivariable survival analyses were applied investigating falls and/or hip fractures as outcomes. Results: In 22,103 older adults, incidence rates were 60.1 per 100…

PediatricsNursing(all)Hip fractureCohort Studies0302 clinical medicineRisk FactorsLondon*mental illnessOriginal Study030212 general & internal medicineGeneral Nursingeducation.field_of_studyHip fracture*substance use disordersubstance use disorderIncidenceHealth PolicyIncidence (epidemiology)General Medicinemental illnessMental Healthpopulation characteristicsmedicine.symptom/dk/atira/pure/subjectarea/asjc/2900medicine.medical_specialtyPopulation03 medical and health sciencesfalls dementiaparasitic diseasesmedicineHumansBipolar disordermental illneeducationAgedRetrospective StudiesHip Fracturesbusiness.industry*schizophreniaRetrospective cohort study/dk/atira/pure/subjectarea/asjc/2700/2717*Hip fracture/dk/atira/pure/subjectarea/asjc/2700/2719medicine.diseaseMental illnessMental healthschizophreniaDeliriumAccidental FallsHuman medicine*falls dementiaGeriatrics and Gerontologybusiness030217 neurology & neurosurgery
researchProduct

Interplay between cognition and weight reduction in individuals following a Mediterranean Diet: Three-year follow-up of the PREDIMED-Plus trial

2021

Background & aims: Some cognitive profiles might facilitate successful weight loss and its maintenance. Also, weight reductions may result in cognitive benefits. However, little work to date has examined the interactions between cognition and weight changes in the context of interventions with the Mediterranean diet (MedDiet). We studied the within-subject longitudinal relationships between cognition, body mass index (BMI), physical activity (PA), and quality of life (QoL), in older adults following a MedDiet. Methods: The PREDIMED-Plus is a primary prevention trial testing the effect of a lifestyle intervention program with an energy-restricted MedDiet (er-MedDiet), weight-loss goals and P…

MaleGerontologyOverweightDiet MediterraneanCritical Care and Intensive Care MedicineBody Mass IndexNutrition PolicyCognitionQuality of lifeMemoryWeight lossMediterranean dietWeight LossmedicineHumansLongitudinal StudiesObesityEffects of sleep deprivation on cognitive performanceExerciseAgedNutritionMetabolic SyndromeNutrition and Dieteticsbusiness.industryPreventionCognitionOverweightMental Status and Dementia TestsExecutive functionsTreatment OutcomeQuality of LifeFemaleGuideline Adherencemedicine.symptomVerbal memorybusinessNeurocognitiveFollow-Up StudiesClinical Nutrition
researchProduct

Frontotemporal dementia: the post-tau era.

2006

As scientists have begun to decipher the molecular genetic bases of hereditary frontotemporal dementia (FTD), it has become clear that the biology of these human neurodegenerative diseases has a complexity not previously suspected. FTD has been found to be linked to several chromosomal loci including those in chromosome 9, chromosome 17, and chromosome 3. The article by Guyant-Marechal et al. in this issue of Neurology reports the clinical, pathologic, and molecular characteristics of a form of FTD associated with inclusion body myopathy and Paget disease of the bone observed in members of two families and expands our knowledge on genetically determined FTD.1 The disorder is associated with…

MaleHeterozygoteMultiple Organ FailureDNA Mutational AnalysisChromosome 9Cell Cycle ProteinsChromosome Disorderstau ProteinsBiologyRisk AssessmentMyositis Inclusion BodyExonRisk FactorsValosin Containing ProteinmedicinePrevalenceHumansGenetic Predisposition to DiseaseGeneRetrospective StudiesGeneticsAdenosine TriphosphatasesIncidenceChromosomeSyndromeMiddle Agedmedicine.diseaseOsteitis DeformansPhenotypePedigreeChromosome 17 (human)Chromosome 3MutationDementiaFemaleNeurology (clinical)FranceFrontotemporal dementiaNeurology
researchProduct

''Motor Resonance Mechanisms Are Preserved In Alzheimer's Disease Patients''

2012

Bisio, A. | Casteran, M. | Ballay, Y. | Manckoundia, P. | Mourey, F. | Pozzo, T.; International audience; ''This study aimed to better characterize the sensorimotor mechanisms underlying motor resonance, namely the relationship between motion perception and movement production in patients suffering from Alzheimer's disease (AD). This work first gives a kinematic description of AD patients' upper limb movements, then it presents a simple paradigm in which a dot with different velocities is moved in front of the participant who is instructed to point to its final position when it stopped. AD patients' actions, as well as healthy elderly participants, were similarly influenced by the dot veloc…

MaleMILD COGNITIVE IMPAIRMENTData InterpretationInhibition (Psychology)DiseaseNeuropsychological TestsHUMAN AUTONOMYExecutive FunctionCognition80 and overAged 80 and overMovement observation-executionGeneral NeuroscienceMIRROR NEURONSCognitionStatisticalAction-perception matchingAction-perception matching; Ageing; Automatic imitation; Dementia; Movement observation-execution; Aged; Aged 80 and over; Alzheimer Disease; Arm; Biomechanical Phenomena; Cognition; Data Interpretation Statistical; Executive Function; Female; Humans; Inhibition (Psychology); Linear Models; Male; Movement; Neuropsychological Tests; Photic Stimulation; Psychomotor Performance; Neuroscience (all)Biomechanical PhenomenaInhibition PsychologicalSOCIAL COGNITIONData Interpretation Statistical[ SCCO.NEUR ] Cognitive science/NeuroscienceArmFemaleAlzheimer's diseasePsychologyMovementStimulus (physiology)Alzheimer DiseaseCOLOR-WORD TESTmedicineHumansDementiaREACTION-TIME''Motion perceptionREACTION-TIMENEURAL MECHANISMSMotor resonanceAgedNeuroscience (all)Healthy elderlyPOINTING MOVEMENTSmedicine.diseaseFRONTAL LOBESVISUOMOTOR INTEGRATIONAgeing''MILD COGNITIVE IMPAIRMENTLinear ModelsDementiaNeuroscienceAutomatic imitationPhotic StimulationPsychomotor Performance
researchProduct

En kartlegging av teknologiske hjelpemidler til personer med nyoppdaget demens

2014

Masteroppgave i helse- og sosialinformatikk HSI 500 Universitetet i Agder 2014 The main objective of the national program of welfare technology is that welfaretechnological solutions will be an integrated part of the health and care services within 2020.Several projects in this program will include safety packages. Before technological tools areimplemented, a survey regarding the needs and challenges should be conducted. The presentstudy has focused on people with dementia and their relatives, because in 2040, the number ofpeople with dementia is expected to double.Welfare technological solutions can be divided into three parts: fall, isolation, and cognitiveimpairment. Thus, the current st…

HSI500VDP::Technology: 500::Information and communication technology: 550Velferdsteknologi demens trygghetspakke ; teknologiske hjelpemidler ; welfare technology ; dementia ; safety packages ; technological tools
researchProduct

The relationship between Polypharmacy and Trajectories of Cognitive Decline in People with Dementia: a large representative cohort study

2019

Polypharmacy, defined through the number of medications prescribed, has been linked to a range of adverse health outcomes in people with dementia. It is however unclear whether a numerical threshold of concurrently prescribed drugs is a suitable predictor for cognitive decline. We aimed to test associations between polypharmacy and both short-term (six months) and long-term (three years) cognitive trajectories in patients with incident dementia. Using data from a large mental health and dementia care database in South London, a cohort of 12,148 patients (mean age = 80.7 years, 61.1% female, mean MMSE = 18.6) clinically diagnosed with dementia was identified. We determined the number of medi…

Male0301 basic medicineGerontologyAgingCognitive declineBiochemistryCohort Studies03 medical and health sciencesCognitionCommunity care0302 clinical medicineEndocrinologyA large representative cohort study.- Experimental gerontology cilt.120 ss.62-67 2019 [Soysal P. Perera G. Isik A. Onder G. Petrovic M. Cherubini A. Maggi S. Shetty H. Molokhia M. Smith L. et al. -The relationship between polypharmacy and trajectories of cognitive decline in people with dementia]mental disordersGeneticsmedicineHumansDementiaCognitive DysfunctionCognitive declineassociations between polypharmacyMolecular BiologyAgedAged 80 and overPolypharmacypeople with dementia.Mini–Mental State Examinationmedicine.diagnostic_testbusiness.industryCognition; Cognitive decline; Community care; Dementia; PolypharmacyCognitionlong-term (three years)Cell BiologyMental Status and Dementia Testsmedicine.diseaseComorbidity030104 developmental biologyCohortPolypharmacyFemaleDementiabusinessshort-term (six months)030217 neurology & neurosurgeryCohort study
researchProduct

DCTN1 mutation analysis in Italian patients with PSP, MSA, and DLB

2020

Abstract DCTN1 encodes the largest subunit of dynactin complex essential in the retrograde axonal transport and cytoplasmic transport of vesicles; mutations in DCTN1 have been reported predominantly in individuals with Perry syndrome and, recently, in patients with progressive supranuclear palsy. Our genetic screening of DCTN1 in 79 patients with progressive supranuclear palsy, 100 patients with multiple system atrophy, and 28 patients with dementia with Lewy bodies from Italy revealed only synonymous and intronic variants, suggesting that DCTN1 mutations do not have a key role in the development of atypical parkinsonism in the Italian population.

Lewy Body DiseaseMale0301 basic medicineAgingPathologymedicine.medical_specialtyDementia with Lewy bodieDNA Mutational AnalysisDynactinProgressive supranuclear palsy03 medical and health sciences0302 clinical medicineAtrophymedicineHumansIn patientGenetic TestingGenetic Association StudiesAgedDCTN1Dementia with Lewy bodiesbusiness.industryProgressive supranuclear palsyGeneral NeuroscienceParkinson DiseaseDynactin ComplexMiddle AgedMultiple System Atrophymedicine.diseaseDCTN1030104 developmental biologyItalyMutation testingDynactinAxoplasmic transportDCTN1; Dementia with Lewy bodies; Dynactin; Multiple system atrophy; Progressive supranuclear palsyFemaleSupranuclear Palsy ProgressiveNeurology (clinical)Geriatrics and GerontologybusinessNegative Results030217 neurology & neurosurgeryDevelopmental BiologyNeurobiology of Aging
researchProduct

Analysis of the LRP10 gene in patients with Parkinson's disease and dementia with Lewy bodies from Southern Italy

2020

Recently, the LRP10 gene has been associated with Parkinson's disease (PD), Parkinson's disease with dementia (PDD), and dementia with Lewy bodies (DLB). The aim of the present study was to evaluate the presence of mutations of the LRP10 gene in patients with PD or DLB from Southern Italy. Sequencing analysis revealed only 2 missense and 3 synonymous variants in patients and control subjects and a rare variant p.L622F in a PD case. These results suggest that LRP10 mutations are not a frequent cause of PD and DLB in Southern Italy.

Lewy Body Diseasemedicine.medical_specialtyNeurologyParkinson's diseaseLRP10 . Parkinson’s disease . Dementia with Lewy bodiesDermatologyDiseasebehavioral disciplines and activities03 medical and health sciences0302 clinical medicineAlzheimer DiseaseInternal medicineDementia with Lewy bodies; LRP10; Parkinson's disease.mental disordersmedicineDementiaMissense mutationHumans030212 general & internal medicineNeuroradiologyDementia with Lewy bodiesbusiness.industryParkinson DiseaseGeneral Medicinemedicine.diseasenervous system diseasesPsychiatry and Mental healthItalyMutationSettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerybusiness030217 neurology & neurosurgery
researchProduct